Global Neurometabolic Disorders Market- 2020-2027
Global Neurometabolic Disorders Market is segmented By Disease Type (Amino Acid Disorders (Phenylketonuria, Maple Syrup Urine Disease, Others), Carbohydrate Metabolism Disorders (Diabetes), Mitochondrial Disorders (Friedreich Ataxia, Wilson Disease), Peroxisomal Disorders (Zellweger Syndrome, Adrenoleukodystrophy), Lysosomal Storage Disorders (Hunter Syndrome, Gaucher Disease, Fabry Disease, Others (Krabbe Disease, Tay-Sachs Disease, Niemann-Pick Disease)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2020-2027
Market Overview
The Global Neurometabolic Disorders Market is expected to grow at a high CAGR of 8.5% during the forecasting period (2020-2027).
Why Purchase the Report?
Visualize the composition of the Neurometabolic Disorders Market across each indication, regarding type and treatment options, highlighting the vital commercial assets and players.
Identify business opportunities in Neurometabolic Disorders Market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of the Neurometabolic Disorders Market – level 4/5 segmentation.
A PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the principal products of all major market players
Target Audience
Equipment Suppliers/ Buyers
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
Research Professionals
Emerging Companies
Manufacturers
- Global Neurometabolic Disorders Market Methodology and Scope
- Research Methodology
- Research Objective and Scope of the Report
- Global Neurometabolic Disorders Market – Market Definition and Overview
- Global Neurometabolic Disorders Market – Executive Summary
- Market Snippet by Disease Type
- Market Snippet by Region
- DataM CLO Scenario
- Global Neurometabolic Disorders Market – Market Dynamics
- Market Impacting Factors
- Drivers
- Increase in prevalence of neurometabolic disorders
- Technological advancements
- Supportive government policies
- Restraints
- High R&D investments
- High cost of drugs
- Opportunity
- Impact Analysis
- Global Neurometabolic Disorders Market – Industry Analysis
- Porter's Five Forces Analysis
- Regulatory Analysis
- Epidemiology
- Global Neurometabolic Disorders Market – By Disease Type
- Introduction
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- Market Attractiveness Index, By Disease Type
- Amino Acid Disorders
- Introduction
- Market Size Analysis, and Y-o-Y Growth Analysis (%)
- Phenylketonuria
- Maple Syrup Urine Disease
- Others
- Carbohydrate Metabolism Disorders
- Diabetes
- Mitochondrial Disorders
- Friedreich Ataxia
- Wilson Disease
- Peroxisomal Disorders
- Zellweger Syndrome
- Adrenoleukodystrophy
- Lysosomal Storage Disorders
- Hunter Syndrome
- Gaucher Disease
- Fabry Disease
- Others (Krabbe Disease, Tay-Sachs Disease, Niemann-Pick Disease)
- Global Neurometabolic Disorders Market – By Region
- Introduction
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
- Market Attractiveness Index, By Region
- North America
- Introduction
- Key Region-Specific Dynamics
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- U.S.
- Canada
- Mexico
- Europe
- Introduction
- Key Region-Specific Dynamics
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- South America
- Introduction
- Key Region-Specific Dynamics
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- Introduction
- Key Region-Specific Dynamics
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- China
- India
- Japan
- Australia
- Rest of Asia Pacific
- Middle East and Africa
- Introduction
- Key Region-Specific Dynamics
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- Global Market – Competitive Landscape
- Competitive Scenario
- Competitor Neurometabolic Disorders Strategy Analysis
- Comparative Product Portfolio Analysis
- Market Positioning/Share Analysis
- Mergers and Acquisitions Analysis
- Global Market – Company Profiles
- Amicus Therapeutics *
- Company Overview
- Product Portfolio and Description
- Key Highlights
- Financial Overview
- ISU Abxis
- JCR Pharmaceuticals
- Biosidus
- Greenovation Biotech
- Lixte Biotechnology Holdings, Inc.
- Pharming Group N.V.
- Protalix BioTherapeutics
- Amicus
- Biomarin
- Sanofi
- Shire
- Celerion
- Orchard Therapeutics plc
- Global Neurometabolic Disorders Market – Premium Insights
- Global Neurometabolic Disorders Market – DataM
- Appendix
- About Us and Services
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook